June 21, 2017 - By Adrian Mccoy
Arcos Dorados Holdings Incorporated (NYSE:ARCO) had an increase of 35.77% in short interest. ARCO’s SI was 391,300 shares in June as released by FINRA. Its up 35.77% from 288,200 shares previously. With 1.12 million avg volume, 0 days are for Arcos Dorados Holdings Incorporated (NYSE:ARCO)’s short sellers to cover ARCO’s short positions. The SI to Arcos Dorados Holdings Incorporated’s float is 0.3%. About 185,092 shares traded. Arcos Dorados Holding Inc (NYSE:ARCO) has risen 102.55% since June 21, 2016 and is uptrending. It has outperformed by 85.85% the S&P500.
Parsec Financial Management Inc decreased Cvs Health (CVS) stake by 1.53% reported in 2016Q4 SEC filing. Parsec Financial Management Inc sold 4,197 shares as Cvs Health (CVS)’s stock declined 4.23%. The Parsec Financial Management Inc holds 270,381 shares with $21.34M value, down from 274,578 last quarter. Cvs Health now has $79.72B valuation. The stock rose 1.02% or $0.79 reaching $78.57. About 1.91M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 21, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.
Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.33B for 14.99 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.
Since February 1, 2017, it had 0 buys, and 7 selling transactions for $40.53 million activity. 23,849 shares were sold by Brennan Troyen A, worth $1.88 million on Tuesday, March 21. $479,908 worth of CVS Health Corp (NYSE:CVS) was sold by Boratto Eva C on Friday, March 17. Sussman Andrew also sold $1.13 million worth of CVS Health Corp (NYSE:CVS) shares. Denton David M had sold 230,510 shares worth $18.44 million on Monday, June 12. 76,494 shares were sold by MERLO LARRY J, worth $5.99M on Wednesday, February 1. Another trade for 61,196 shares valued at $4.90M was sold by Roberts Jonathan C.
Parsec Financial Management Inc increased Ishares Nasdaq Biotechnology (IBB) stake by 3,961 shares to 14,445 valued at $3.83M in 2016Q4. It also upped United Technologies (NYSE:UTX) stake by 4,616 shares and now owns 92,302 shares. Kinder Morgan Inc (NYSE:KMI) was raised too.
Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by Mizuho given on Wednesday, November 9. Deutsche Bank maintained it with “Hold” rating and $121 target in Thursday, August 20 report. Deutsche Bank maintained CVS Health Corp (NYSE:CVS) rating on Wednesday, July 22. Deutsche Bank has “Hold” rating and $117 target. The stock of CVS Health Corp (NYSE:CVS) earned “Neutral” rating by Citigroup on Monday, May 9. The rating was initiated by UBS with “Buy” on Thursday, October 6. S&P Research maintained the stock with “Strong Buy” rating in Monday, November 2 report. The stock of CVS Health Corp (NYSE:CVS) earned “Overweight” rating by JP Morgan on Monday, November 2. The company was maintained on Thursday, May 12 by Jefferies. The stock of CVS Health Corp (NYSE:CVS) earned “Outperform” rating by Oppenheimer on Friday, August 28. The stock of CVS Health Corp (NYSE:CVS) earned “Buy” rating by Mizuho on Thursday, June 23.
Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It fall, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Wellington Shields & Com Lc stated it has 0.3% in CVS Health Corp (NYSE:CVS). Virtu Fincl invested in 5,020 shares. 13,594 were accumulated by Independent Portfolio Consultants. Summit Asset Mngmt Limited Com invested in 5,064 shares or 0.25% of the stock. Mechanics Commercial Bank Department owns 56,755 shares or 1.08% of their US portfolio. Cypress Mgmt Ltd Com invested in 7,945 shares or 0.17% of the stock. 8,297 are owned by Iberiabank Corp. Davenport & Company Ltd holds 0.48% or 423,808 shares in its portfolio. Atwood Palmer Inc accumulated 197,620 shares or 2.81% of the stock. Meeder Asset Mgmt has invested 0% in CVS Health Corp (NYSE:CVS). North American Mgmt has invested 0.19% in CVS Health Corp (NYSE:CVS). Insight 2811 accumulated 7,000 shares or 0.45% of the stock. Kidder Stephen W reported 3.29% stake. Price T Rowe Associate Inc Md has 7.54 million shares for 0.12% of their portfolio. The Japan-based Blackrock Japan has invested 0.44% in CVS Health Corp (NYSE:CVS).
Among 3 analysts covering Arcos Dorados Holdings Inc. (NYSE:ARCO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Arcos Dorados Holdings Inc. had 4 analyst reports since August 12, 2015 according to SRatingsIntel. Bank of America downgraded it to “Neutral” rating and $5 target in Wednesday, August 12 report. The firm has “Neutral” rating given on Monday, December 7 by Citigroup. The stock of Arcos Dorados Holding Inc (NYSE:ARCO) has “Buy” rating given on Tuesday, April 11 by Bank of America. Morgan Stanley upgraded the stock to “Overweight” rating in Monday, October 24 report.
Arcos Dorados Holdings Inc. is a McDonald’s franchisee. The company has market cap of $1.58 billion. The Firm operates or franchises over 2,140 McDonald’s-branded restaurants. It has a 15.75 P/E ratio. It divides its activities into four geographical divisions: Brazil; the Caribbean division, consisting of Aruba, Colombia, Curacao, French Guiana, Guadeloupe, Martinique, Puerto Rico, Trinidad and Tobago, the United States Virgin Islands of Saint Croix and Saint Thomas, and Venezuela; the North Latin America division , consisting of Costa Rica, Mexico and Panama, and the South Latin America division (SLAD), consisting of Argentina, Chile, Ecuador, Peru and Uruguay.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.